Caldwell Sutter Capital’s ResMed RMD Stock Holding History

Caldwell Sutter Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$488	–	914
2024 Q3	$488	Hold	2	–	–	﹤0.01%	855
2024 Q2	$383	Hold	2	–	–	﹤0.01%	877
2024 Q1	$396	Sell	2 -3	-60%	-$550	﹤0.01%	866
2023 Q4	$860	Buy	+5	New	+$768	﹤0.01%	843

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Caldwell Sutter Capital's RMD Position: Q4 2024 in Review

Caldwell Sutter Capital sold out of ResMed (RMD) in Q4 2024, closing a stake of 2 shares — an estimated $488 sold.

Caldwell Sutter Capital first reported a position in RMD in Q4 2023 and held it in 4 quarters. The position peaked at $860 in Q4 2023. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

Caldwell Sutter Capital reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
Caldwell Sutter Capital sold 2 ResMed shares in Q4 2024, an estimated $488.
Caldwell Sutter Capital first reported a position in ResMed in Q4 2023 and held it in 4 quarters.
Caldwell Sutter Capital's ResMed position peaked at $860 in Q4 2023.
871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Caldwell Sutter Capital's 13F filing for Q4 2024, filed 21 Jan 2025.